机译:ombatasvir / paritaprevir / ritonavir和利巴韦林对日本基因型2a感染慢性肝炎患者的慢性肝炎患者的疗效和安全性
Division of Gastroenterology and Hepatology Department of Internal MedicineNippon Medical;
Core Research Facilities for Basic Science Research Center for Medical SciencesJikei University;
Department of GastroenterologyOgaki Municipal HospitalOgaki;
Department of HepatologyKagawa Prefectural Central HospitalTakamatsu;
Department of GastroenterologyNational Hospital Organization Kyushu Medical CenterFukuoka;
Department of Internal MedicineSt. Marianna University School of MedicineKawasaki;
Department of GastroenterologyOgaki Municipal HospitalOgaki;
Department of HepatologyKagawa Prefectural Central HospitalTakamatsu;
Department of Internal MedicineSt. Marianna University School of MedicineKawasaki;
Department of Gastroenterology and HepatologyShinmatsudo Central General HospitalMatsudo;
Department of Gastroenterology and HepatologyShinmatsudo Central General HospitalMatsudo;
Department of Gastroenterology Internal MedicineKitasato University School of MedicineSagamihara;
Department of Internal Medicine Division of Gastroenterology HepatologyTokyo Medical;
Department of Internal Medicine Division of Gastroenterology and HepatologyTokyo Metropolitan;
Division of Gastroenterology and Hepatology Department of Internal MedicineNippon Medical;
Department of Internal Medicine Division of GastroenterologyNippon Medical School Chiba Hokusoh;
Department of Internal Medicine Division of GastroenterologyNippon Medical School Chiba Hokusoh;
Department of Internal Medicine Division of GastroenterologyNippon Medical School Chiba Hokusoh;
Department of Internal Medicine Division of GastroenterologyNippon Medical School Chiba Hokusoh;
Department of Internal Medicine Division of GastroenterologyNippon Medical School Chiba Hokusoh;
Department of GastroenterologyOgaki Municipal HospitalOgaki;
Division of Gastroenterology and Hepatology Department of Internal MedicineNippon Medical;
chronic hepatitis; genotype 2a; ombitasvir/paritaprevir/ritonavir; ribavirin;
机译:ombatasvir / paritaprevir / ritonavir和利巴韦林对日本基因型2a感染慢性肝炎患者的慢性肝炎患者的疗效和安全性
机译:慢性丙基肝炎病毒基因型1A感染患者慢性丙型肝炎病毒基因型1A感染患者的疗效和安全性的疗效和安全性和Dasbuvir
机译:Ombitasvir / Paritaprevir / Ritonavir和Dasabuvir联合或不联合利巴韦林在接受阿片类药物替代治疗的慢性丙型肝炎病毒基因型1感染患者中的疗效和安全性:对12项临床试验的事后分析
机译:胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
机译:利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
机译:Ombitasvir / Paritaprevir / Ritonavir和Dasabuvir联合或不联合利巴韦林在接受阿片类药物替代治疗的慢性丙型肝炎病毒基因型1感染患者中的疗效和安全性:对12项临床试验的事后分析
机译:慢性丙基肝炎病毒基因型1A感染患者慢性丙基肝炎病毒基因型1A感染的疗效和Dasabuvir和Dasbuvir的疗效和安全性